Why Edgewise Therapeutics Stock Crushed the Market on Monday
Source: Motley Fool
2026-02-09 20:25:54 ET
As investors, we should never underestimate the power of a convincing buy recommendation from an analyst. That was the dynamic behind the impressive rise of Edgewise Therapeutics (NASDAQ: EWTX) stock on Monday; after a pundit who's been tracking the biotech for some time reiterated her bullish view on its potential, investors traded it up by 4% on the day. That crushed the 0.5% increase of the bellwether S&P 500 index.
The analyst in question was Piper Sandler 's Yasmeen Rahimi. Monday morning, she reiterated her overweight recommendation on Edgewise's equity and her $51 per share price target.
Image source: Getty Images.
Edgewise Therapeutics Inc.
NASDAQ: EWTX
EWTX Trading
15.75% G/L:
$39.055 Last:
2,691,761 Volume:
$40.60 Open:
EWTX Latest News
June 01, 2026 08:30:00 am
Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
EWTX Stock Data
$3,280,862,770
54,628,112
N/A
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Boulder
